<!DOCTYPE html> 
<html> 
	<head>
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width, minimum-scale=1, maximum-scale=1"> 
	<title>Co Occuring Conditions Toolkit Background</title> 

</head> 
<body> 

<div data-role="page">

	<div data-role="header" data-theme="b">
		<h1>Treatment Analysis</h1>
		<a href="#" data-rel="back" data-icon="arrow-l" data-direction="reverse" class="ui-btn-left jqm-home">Back</a>
	</div><!-- /header -->

	<div data-role="content">
			
			
				<h4>Case Vignette: Treatment Analysis</h4>
				<p>His primary care provider initiated treatment with a seven day course of a triazolam 3mg, based on his primary complaint of sleep disturbance and scheduled a follow up visit in 14 days. Upon returning for follow up, SGT King, reported that the medication helped him to sleep through the night, but he discontinued its use after he could not wake up during a distressing nightmare. He felt increased anxiety for several days following this incident. He also noted that he was increasingly forgetful on the medication. At this time, the PTSD Check List (PCL) and Patient Health Questionnaire-9 (PHQ-9) were administered. SGT King reported a high degree of symptoms consistent with PTSD (PCL total=67), and moderate levels of depression (PHQ-9 total=10). Notably, SGT King's pattern of symptom endorsement included that he was extremely bothered (rating of 5 on 1-5 scale) by disturbing dreams of a stressful experience (item #3). Based upon further information gleaned during a more thorough clinical assessment, SGT King began a successful treatment regimen by his primary</p>		
			
	</div><!-- /content -->
</div><!-- /page -->

</body>
</html>